JULIE ALIMI

About JULIE ALIMI

Julie Alimi serves at Medincell as General Counsel and Chief Corporate Development Officer, a senior executive role that combines legal oversight, corporate governance, and strategic development responsibilities. At this listed biopharmaceutical company, which specializes in long-acting injectable therapies, she operates at the intersection of compliance, board governance, market transactions, and business development. Public Medincell sources also refer to her as Head of Legal and later as a leader in corporate development, reflecting a broadening of her remit over time within the group. Julie Alimi is presented in professional profiles as a corporate lawyer with expertise in business law, corporate and commercial law, and intellectual property. Those profiles indicate that she studied law at Montpellier Law School and earned an LL.M. in Intellectual Property from the University of California, Berkeley. Prior to joining Medincell, she held legal and corporate roles, including General Counsel at RioLinx and corporate lawyer positions at Spada Law Firm. She also founded and grew L3S Partnership, a life sciences executive search boutique that was later integrated into Chaberton Partners, where she helped strengthen an international Healthcare & Life Sciences practice. At Medincell, her contribution goes beyond day-to-day legal work. She has been involved in shareholder meetings, regulatory communications, capital markets matters, and the structuring of corporate decisions, as reflected in the company’s public disclosures. Public insider-trading records also show that she has traded Medincell shares, underscoring her direct connection to the company’s equity and governance environment. Overall, Julie Alimi stands out as a high-level corporate executive with a rare combination of legal sophistication, transactional discipline, and deep exposure to the innovation-driven healthcare sector.